BioSpace News Archive

Deals

Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

Cutera, Inc. granted a total of 44,500 non-qualified inducement stock options to six employees.

May 30, 2024
·
1 min read
Deals

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced the grant of inducement awards of options to purchase a collective total of up to 200,000 shares of common stock. An award was made to one new employee of the Company.

May 30, 2024
·
4 min read
Genetown

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City.

May 30, 2024
·
2 min read
Pharm Country

Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune’s TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications

Adaptimmune will hold a conference call tomorrow (May 31st) at 8 a.m. EDT (webcast link here and more details below)

May 30, 2024
·
8 min read
Business

CooperCompanies Announces Second Quarter 2024 Results

CooperCompanies, a leading global medical device company, announced financial results for its fiscal second quarter ended April 30, 2024.

May 30, 2024
·
19 min read
BioCapital

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Supernus Pharmaceuticals, Inc. announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 1:30 p.m. ET at the Marriott Marquis Hotel in New York City.

May 30, 2024
·
4 min read
Pharm Country

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York

Verrica Pharmaceuticals Inc. today announced that Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City.

May 30, 2024
·
1 min read
Genetown

Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference

Dianthus Therapeutics, Inc. today announced its participation in the Jefferies Global Healthcare Conference. Marino Garcia, Chief Executive Officer, will present a corporate overview on Thursday, June 6, 2024 at 1:30 p.m. ET in New York.

May 30, 2024
·
4 min read
Lone Star Bio

Researchers take step toward development of universal COVID-19 antibodies

SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions.

May 30, 2024
·
3 min read
SAB Biotherapeutics Announces Departure of Chief Financial Officer

SAB Biotherapeutics today announced that effective June 4, its Chief Financial Officer Michael King will be departing the company to accept a role as CEO at a privately-held oncology company.

May 30, 2024
·
4 min read